8-K
filed August 5, 2021, 7:59 PM ET
ticker GH
CIK 0001576280
leadership
confidence high
sentiment neutral
materiality 0.65
Guardant Health names co-CEOs, splits oncology and screening groups; adds Meghan Joyce to board
Guardant Health, Inc.
- Helmy Eltoukhy and AmirAli Talasaz appointed co-CEOs effective Aug 5, 2021; Eltoukhy becomes Chairman.
- Talasaz steps down as COO but remains President; Eltoukhy leads oncology, Talasaz screening division.
- Meghan Joyce, Oscar Health COO/EVP, named independent director; joined audit and compensation committees.
- Joyce received initial stock option and RSU awards each valued at $362,500 under director compensation plan.
- Company plans blood-based screening LDT launch in 2022 and cites recent launches of Reveal, TissueNext, Response.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Meghan Joyce was appointed as Class II director at Guardant Health, Inc..
- Action
- appointed
- Role
- Class II director
Exact text from the filing
the Board increased the number of directors on the Board to eight and appointed Meghan Joyce as a Class II director
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Helmy Eltoukhy changed role as Co-Chief Executive Officer at Guardant Health, Inc..
- Action
- changed title
- Role
- Co-Chief Executive Officer
Exact text from the filing
changed the title of Helmy Eltoukhy, the Company’s current Chief Executive Officer, to the Company’s Co-CEO
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
AmirAli Talasaz resigned as Chief Operating Officer at Guardant Health, Inc..
- Action
- resigned
- Role
- Chief Operating Officer
Exact text from the filing
Dr. Talasaz has also announced his intent to resign from his position as Chief Operating Officer of the Company
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
AmirAli Talasaz was appointed as Co-Chief Executive Officer at Guardant Health, Inc..
- Action
- appointed
- Role
- Co-Chief Executive Officer
Exact text from the filing
the Company appointed AmirAli Talasaz as the Company’s Co-CEO
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
AmirAli Talasaz resigned as Chairperson of the Board at Guardant Health, Inc..
- Action
- resigned
- Role
- Chairperson of the Board
Exact text from the filing
Dr. Talasaz announced his intent to resign from his position as Chairperson of the Board
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.